Latham & Watkins LLP represented Angion in the offering and private placement.Angion Biomedica Corp. (NASDAQ:ANGN) has announced the pricing of its initial public offering of 5 million…
Angion Biomedica’s Initial Public Offering and Concurrent Private Placement
